OKYO Pharma (OKYO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.41, -1.40% vs the prior close of $1.43.
- Volume 25.64K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OKYO dips 1.4% to $1.41. Closed at $1.41, -1.40% vs the prior close of $1.43. Day range $1.40–$1.43, opened at $1.43.
OKYO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OKYO dips 1.4% to $1.41
- Closed at $1.41, -1.40% vs the prior close of $1.43. Day range $1.40–$1.43, opened at $1.43.
- Volume was 25.64K shares, 0.4x its 50-day average of 70.56K — lighter than usual.
- Price is -3.1% vs its 50-day average ($1.45) and -15.4% vs its 200-day average ($1.67).
- 52-week range $1.26–$3.20; today's close sits at 7% of that range, 55.9% below the 52-week high.
Oct 15, 2026 — OKYO rises 1.1% to $1.43
- Closed at $1.43, +1.06% vs the prior close of $1.41. Day range $1.40–$1.46, opened at $1.42.
- Volume was 48.90K shares, 0.7x its 50-day average of 70.90K.
- Price is -1.9% vs its 50-day average ($1.46) and -14.4% vs its 200-day average ($1.67).
- 52-week range $1.26–$3.20; today's close sits at 9% of that range, 55.3% below the 52-week high.
Oct 14, 2026 — OKYO dips 1.6% to $1.41
- Closed at $1.41, -1.60% vs the prior close of $1.44. Day range $1.38–$1.45, opened at $1.45.
- Volume was 18.50K shares, 0.3x its 50-day average of 71.49K — lighter than usual.
- Price is -3.1% vs its 50-day average ($1.46) and -15.4% vs its 200-day average ($1.67).
- 52-week range $1.26–$3.20; today's close sits at 8% of that range, 55.8% below the 52-week high.
Oct 13, 2026 — OKYO ends flat (-0.1%) to $1.44
- Closed at $1.44, -0.14% vs the prior close of $1.44. Day range $1.41–$1.47, opened at $1.46.
- Volume was 20.90K shares, 0.3x its 50-day average of 71.44K — lighter than usual.
- Price is -1.8% vs its 50-day average ($1.46) and -14.2% vs its 200-day average ($1.68).
- 52-week range $1.26–$3.20; today's close sits at 9% of that range, 55.1% below the 52-week high.
Oct 12, 2026 — OKYO rises 1.4% to $1.44
- Closed at $1.44, +1.41% vs the prior close of $1.42. Day range $1.40–$1.49, opened at $1.46.
- Volume was 70.40K shares, 1.0x its 50-day average of 70.54K.
- Price is -2.0% vs its 50-day average ($1.47) and -14.2% vs its 200-day average ($1.68).
- 52-week range $1.26–$3.20; today's close sits at 9% of that range, 55.0% below the 52-week high.
Oct 9, 2026 — OKYO rises 2.2% to $1.42
- Closed at $1.42, +2.16% vs the prior close of $1.39. Day range $1.35–$1.53, opened at $1.40.
- Volume was 115.50K shares, 1.7x its 50-day average of 68.89K.
- Price is -3.7% vs its 50-day average ($1.47) and -15.5% vs its 200-day average ($1.68).
- 52-week range $1.26–$3.20; today's close sits at 8% of that range, 55.6% below the 52-week high.
Oct 8, 2026 — OKYO dips 1.4% to $1.39, 4 down days in a row
- Closed at $1.39, -1.42% vs the prior close of $1.41. Day range $1.35–$1.46, opened at $1.43.
- Volume was 27.50K shares, 0.4x its 50-day average of 70.84K — lighter than usual.
- Price is -6.0% vs its 50-day average ($1.48) and -17.5% vs its 200-day average ($1.68).
- 52-week range $1.26–$3.20; today's close sits at 6% of that range, 56.6% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — OKYO slides 3.4% to $1.41, 3 down days in a row
- Closed at $1.41, -3.42% vs the prior close of $1.46. Day range $1.36–$1.48, opened at $1.45.
- Volume was 33.70K shares, 0.5x its 50-day average of 71.87K — lighter than usual.
- Price is -5.0% vs its 50-day average ($1.48) and -16.5% vs its 200-day average ($1.69).
- 52-week range $1.26–$3.20; today's close sits at 7% of that range, 55.9% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — OKYO dips 0.7% to $1.46
- Closed at $1.46, -0.68% vs the prior close of $1.47. Day range $1.46–$1.49, opened at $1.48.
- Volume was 30.40K shares, 0.4x its 50-day average of 73.89K — lighter than usual.
- Price is -1.9% vs its 50-day average ($1.49) and -13.6% vs its 200-day average ($1.69).
- 52-week range $1.26–$3.20; today's close sits at 10% of that range, 54.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 5, 2026 — OKYO ends flat (+0.0%) to $1.47
- Closed at $1.47, +0.00% vs the prior close of $1.47. Day range $1.43–$1.47, opened at $1.46.
- Volume was 11.20K shares, 0.2x its 50-day average of 74.58K — lighter than usual.
- Price is -1.5% vs its 50-day average ($1.49) and -13.1% vs its 200-day average ($1.69).
- 52-week range $1.26–$3.20; today's close sits at 11% of that range, 54.1% below the 52-week high.
Oct 2, 2026 — OKYO jumps 9.7% to $1.47
- Closed at $1.47, +9.70% vs the prior close of $1.34. Day range $1.33–$1.47, opened at $1.33.
- Volume was 82.50K shares, 1.1x its 50-day average of 78.01K.
- Price is -1.6% vs its 50-day average ($1.49) and -13.2% vs its 200-day average ($1.69).
- 52-week range $1.26–$3.20; today's close sits at 11% of that range, 54.1% below the 52-week high.
OKYO latest news & SEC filings
Every SEC filing by or about OKYO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Brancaccio John P bought 5,000 shares at $1.48 (≈$7.40K) on Jul 21, 2026
- Brancaccio John P bought 5,000 shares at $1.48 (≈$7.40K) on Jul 21, 2026
- Brancaccio John P bought 5,000 shares at $1.48 (≈$7.40K) on Jul 21, 2026
- Brancaccio John P bought 5,000 shares at $1.48 (≈$7.40K) on Jul 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Dempsey Robert John bought 15,000 shares at $1.54 (≈$23.10K) on Jul 22, 2026
- Dempsey Robert John bought 15,000 shares at $1.54 (≈$23.10K) on Jul 22, 2026
- Dempsey Robert John bought 15,000 shares at $1.54 (≈$23.10K) on Jul 22, 2026
- Dempsey Robert John bought 15,000 shares at $1.54 (≈$23.10K) on Jul 22, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Jacob Gary S bought 3,500 shares at $1.40 (≈$4.90K) on Jul 21, 2026
- Jacob Gary S bought 3,500 shares at $1.40 (≈$4.90K) on Jul 21, 2026
- Jacob Gary S bought 3,500 shares at $1.40 (≈$4.90K) on Jul 21, 2026
- Jacob Gary S bought 3,500 shares at $1.40 (≈$4.90K) on Jul 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Cerrone Gabriele M bought 22,500 shares at $1.45 (≈$32.62K) on Jul 21, 2026
- Cerrone Gabriele M bought 22,500 shares at $1.45 (≈$32.62K) on Jul 21, 2026
- Cerrone Gabriele M bought 22,500 shares at $1.45 (≈$32.62K) on Jul 21, 2026
- Cerrone Gabriele M bought 22,500 shares at $1.45 (≈$32.62K) on Jul 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Cerrone Gabriele M bought 25,000 shares at $1.40 (≈$35.00K) on Jul 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Mantelli Flavio bought 20,000 shares at $1.40 (≈$28.00K) on Jul 21, 2026
- Mantelli Flavio bought 20,000 shares at $1.40 (≈$28.00K) on Jul 21, 2026
- Mantelli Flavio bought 20,000 shares at $1.40 (≈$28.00K) on Jul 21, 2026
- Mantelli Flavio bought 20,000 shares at $1.40 (≈$28.00K) on Jul 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade OKYO
- How much it moves: over the last 20 sessions the average daily move was 2.20% (largest 9.7%).
- Liquidity: about 59.02K shares (≈$83.21K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.41 vs a range of $1.26–$3.20 (7% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Rajkumar V. Patil bought 3,363 shares on Jul 27, 2026.
- Latest filings: 6-K Oct 6, 2026; 6-K Sep 29, 2026; 6-K Sep 9, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
OKYO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.43 | 1.43 | 1.40 | 1.41 | 25.64K |
| Oct 15, 2026 | 1.42 | 1.46 | 1.40 | 1.43 | 48.90K |
| Oct 14, 2026 | 1.45 | 1.45 | 1.38 | 1.41 | 18.50K |
| Oct 13, 2026 | 1.46 | 1.47 | 1.41 | 1.44 | 20.90K |
| Oct 12, 2026 | 1.46 | 1.49 | 1.40 | 1.44 | 70.40K |
| Oct 9, 2026 | 1.40 | 1.53 | 1.35 | 1.42 | 115.50K |
| Oct 8, 2026 | 1.43 | 1.46 | 1.35 | 1.39 | 27.50K |
| Oct 7, 2026 | 1.45 | 1.48 | 1.36 | 1.41 | 33.70K |
| Oct 6, 2026 | 1.48 | 1.49 | 1.46 | 1.46 | 30.40K |
| Oct 5, 2026 | 1.46 | 1.47 | 1.43 | 1.47 | 11.20K |
| Oct 2, 2026 | 1.33 | 1.47 | 1.33 | 1.47 | 82.50K |
| Oct 1, 2026 | 1.29 | 1.35 | 1.26 | 1.34 | 16.90K |
| Sep 30, 2026 | 1.34 | 1.36 | 1.29 | 1.29 | 6.00K |
| Sep 29, 2026 | 1.30 | 1.37 | 1.30 | 1.36 | 44.00K |
| Sep 28, 2026 | 1.36 | 1.39 | 1.31 | 1.37 | 141.70K |
| Sep 25, 2026 | 1.36 | 1.40 | 1.32 | 1.38 | 87.70K |
| Sep 24, 2026 | 1.33 | 1.39 | 1.30 | 1.38 | 87.10K |
| Sep 23, 2026 | 1.37 | 1.37 | 1.30 | 1.32 | 85.20K |
| Sep 22, 2026 | 1.34 | 1.38 | 1.31 | 1.35 | 98.70K |
| Sep 21, 2026 | 1.38 | 1.41 | 1.29 | 1.33 | 127.90K |
About OKYO Pharma
OKYO Pharma (OKYO) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in LONDON, United Kingdom. Fiscal year ends —. SEC CIK 1849296.
OKYO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John P Brancaccio | Director | Aug 7, 2026 |
| Gabriele M Cerrone | Director | Aug 7, 2026 |
| Robert John Dempsey | CHIEF EXECUTIVE OFFICER | Aug 7, 2026 |
| Bernard Denoyer | Director | Jun 10, 2026 |
| Gary S Jacob | CHIEF DEVELOPMENT OFFICER | Aug 7, 2026 |
| Willy Jules Simon | Director | Jun 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert John Dempsey | CHIEF EXECUTIVE OFFICER | Aug 7, 2026 |
| Gary S Jacob | CHIEF DEVELOPMENT OFFICER | Aug 7, 2026 |
| Flavio Mantelli | CHIEF MEDICAL OFFICER | Aug 7, 2026 |
| Rajkumar V. Patil | Chief Scientific Officer | Aug 7, 2026 |
| Keeren Rameshchandra Shah | Chief Financial Officer | Jun 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 27, 2026 | Rajkumar V. Patil | Buy | 3,363 | $1.49 |
| Jul 27, 2026 | Rajkumar V. Patil | Buy | 3,363 | $1.49 |
| Jul 27, 2026 | Rajkumar V. Patil | Buy | 3,363 | $1.49 |
| Jul 27, 2026 | Rajkumar V. Patil | Buy | 3,363 | $1.49 |
| Jul 22, 2026 | Robert John Dempsey | Buy | 15,000 | $1.54 |
| Jul 22, 2026 | Robert John Dempsey | Buy | 15,000 | $1.54 |
| Jul 22, 2026 | Robert John Dempsey | Buy | 15,000 | $1.54 |
| Jul 22, 2026 | Robert John Dempsey | Buy | 15,000 | $1.54 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 22,500 | $1.45 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 22,500 | $1.45 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 22,500 | $1.45 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 22,500 | $1.45 |
| Jul 21, 2026 | Gary S Jacob | Buy | 3,500 | $1.40 |
| Jul 21, 2026 | Gary S Jacob | Buy | 3,500 | $1.40 |
| Jul 21, 2026 | Gary S Jacob | Buy | 3,500 | $1.40 |
OKYO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
OKYO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OKYO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.